Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion

被引:115
作者
Lin, LI
Ke, YF
Ko, YC
Lin, JK
机构
[1] Natl Taiwan Univ, Coll Med, Inst Biochem, Taipei, Taiwan
[2] Natl Taiwan Univ, Coll Med, Sch Med Technol, Taipei, Taiwan
关键词
curcumin; invasion; hepatocellular carcinoma cell; matrix metalloproteinase-9; migration; metastasis;
D O I
10.1159/000011876
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Curcumin (diferuloylmethane), widely used as a spice and coloring agent in food, possesses potent antioxidant, anti-inflammatory and anticarcinogenic properties. Recently, curcumin was further demonstrated to have an antimetastatic effect in mice. In this study, we attempted to clarify the possible mechanisms of this latter effect of curcumin. A highly invasive SK-Hep-1 cell line of human hepatocellular carcinoma (HCC) was selected for this study. An in vitro assay, without or with Matrigel matrix, was used to quantitate cellular migration and invasion. Gelatin-based zymography was adapted to assay the secretion of matrix metalloproteinase (MMP). We found that curcumin, at 10 mu M, inhibited 17.4 and 70.6% of cellular migration and invasion of SK-Hep-1, respectively. Compared with a less invasive human HCC cell line, Huh-7, SK-Hep-l showed a much higher MMP-9 secretion. Further, and parallel with its anti-invasion activity, curcumin inhibited MMP-9 secretion in SK-Hep-l in a dose-dependent fashion. We conclude that curcumin has a significant anti-invasion activity in SK-Hep-l cells, and that this effect is associated with its inhibitory action on MMP-9 secretion.
引用
收藏
页码:349 / 353
页数:5
相关论文
共 33 条
[1]  
ALBINI A, 1987, CANCER RES, V47, P3239
[2]   CHEMOPREVENTIVE EFFECT OF TURMERIC AGAINST STOMACH AND SKIN TUMORS INDUCED BY CHEMICAL CARCINOGENS IN SWISS MICE [J].
AZUINE, MA ;
BHIDE, SV .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1992, 17 (01) :77-83
[3]  
Chen YC, 1996, MOL CARCINOGEN, V17, P224, DOI 10.1002/(SICI)1098-2744(199612)17:4<224::AID-MC6>3.0.CO
[4]  
2-D
[5]  
Fidler I J, 1978, Adv Cancer Res, V28, P149, DOI 10.1016/S0065-230X(08)60648-X
[6]  
FIELER IJ, 1977, SCINCE, V197, P893
[7]  
HUANG HC, 1992, EUR J PHARMACOL, V221, P381
[8]  
HUANG MT, 1988, CANCER RES, V48, P5941
[9]  
HUANG MT, 1991, CANCER RES, V51, P813
[10]  
HUANG MT, 1992, PHENOLIC COMPOUNDS F, P339